Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Cited by (482)

Items 201–300 of 482

1. Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS)
   Nisha Bansal, Ronit Katz, Stephen L. Seliger, Christopher R. deFilippi, Mark J. Sarnak, Joseph A. Delaney, Robert H. Christenson, Ian H. de Boer, Bryan R. Kestenbaum, Cassianne Robinson‐Cohen et al. · 2016 · American Journal of Kidney Diseases
2. Increased Serum Level of Growth Differentiation Factor 15 ( GDF ‐15) is Associated with Coronary Artery Disease
   Xia Wang, Lei‐Lei Chen, Qing Zhang · 2016 · Cardiovascular Therapeutics
3. Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community
   Kai M. Eggers, Tibor Kempf, Anders Olof Larsson, Bertil Lindahl, Per Venge, Lars C. Wallentin, Kai Christoph Wollert, Lars Lind · 2016 · Clinical Chemistry
4. Eplerenone Modulates Interleukin-33/sST2 Signaling and IL-1β in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
   Bo Chen, Jing Geng, Shao-Xi Gao, Wen-Wei Yue, Qiang Liu · 2018 · Journal of Interferon & Cytokine Research
5. Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction
   Masatoshi Minamisawa, Hirohiko Motoki, Atsushi Izawa, Yuichiro Kashima, Hirofumi Hioki, Naoyuki Abe, Takashi Miura, Soichiro Ebisawa, Yusuke Miyashita, Jun Koyama et al. · 2016 · International Heart Journal
6. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation
   Anja Stundl, Nina‐Sophie Lünstedt, Florian Courtz, Sandra Freitag‐Wolf, Norbert Frey, Stefan Holdenrieder, Berndt Zur, Eberhard Grube, Georg Nickenig, Nikos Werner et al. · 2017 · The American Journal of Cardiology
7. The role of cardiac biomarkers in cardiovascular disease risk assessment
   Paul O. Collinson · 2014 · Current Opinion in Cardiology
8. Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.
   Thomas Mueller, Benjamin Dieplinger · 2016 · PubMed Central
9. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study
   Vanessa Pfetsch, Veronika Sanin, Andrea Jaensch, Dhayana Dallmeier, Ute Mons, Hermann Brenner, Wolfgang Köenig, Dietrich Rothenbacher · 2017 · Cardiovascular Drugs and Therapy
10. Increased Growth Differentiation Factor 15 Is Associated with Unfavorable Clinical Outcomes of Acute Ischemic Stroke
    Jieyun Yin, Zhengbao Zhu, Daoxia Guo, Aili Wang, Nimei Zeng, Xiaowei Zheng, Yanbo Peng, Chongke Zhong, Guangli Wang, Yiting Zhou et al. · 2019 · Clinical Chemistry
11. Cardiovascular biomarkers for risk stratification in primary prevention
    Franz–Josef Neumann, James A. de Lemos, Fred S. Apple, Darryl P. Leong · 2025 · European Heart Journal
12. Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses
    the FIBRO-TARGETS investigators, João Pedro Ferreira, Anne Pizard, Jean‐Loup Machu, Emmanuel Bresso, Hans‐Peter Brunner‐La Rocca, Nicolas Girerd, Céline Leroy, Arantxa González, Javier Díez et al. · 2019 · Clinical Research in Cardiology
13. Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation
    Hjørdis Thorsteinsdottir, Cathrin Lytomt Salvador, Geir Mjøen, Anine Lie, Meryam Sugulle, Camilla Tøndel, Atle Brun, Runar Almaas, Anna Kristina Bjerre · 2020 · Disease Markers
14. Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile
    Magdalena Krintus, Marek Koziński, Anna Stefańska, Marcin Sawicki, Karolina Obońska, Tomasz Fabiszak, Jacek Kubica, Grażyna Sypniewska · 2012 · Mediators of Inflammation
15. Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
    Anca Daniela Fărcaș, Florin Petru Anton, Cerasela Mihaela Goidescu, Iulia Laura Gavrilă, Luminiţa Animarie Vida-Simiti, Mirela Anca Stoia · 2017 · Disease Markers
16. Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates
    Berkan Kurt, Konstantin Rex, Martin Reugels, Christopher B. Fordyce, Marat Fudim, Abhinav Sharma, Martin Berger, Nikolaus Marx, Katharina Marx-Schütt, Florian Kahles · 2025 · Current Heart Failure Reports
17. Cardiac troponins: are there any differences between T and I?
    Marco Alfonso Perrone, Simona Storti, Stefano Salvadori, Alessandro Pecori, Sergio Bernardini, Francesco Romeo, Paolo Guccione, Aldo Clerico · 2021 · Journal of Cardiovascular Medicine
18. The Year in Atherothrombosis
    Javier Sanz, Pedro Moreno, Valentín Fuster · 2013 · Journal of the American College of Cardiology
19. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin‐3, and NT‐ProBNP Before Cardiac Surgery
    Sai P. Polineni, Devin M. Parker, Shama S. Alam, Heather Thiessen‐Philbrook, Eric McArthur, Anthony W. DiScipio, David J. Malenka, Chirag R. Parikh, Amit X. Garg, Jeremiah R. Brown · 2018 · Journal of the American Heart Association
20. Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
    Keita Negishi, Satoshi Hoshide, Masahisa Shimpo, Hiroshi Kanegae, Kazuomi Kario · 2021 · Journal of the American Heart Association
21. Growth Differentiation Factor‐15 Predicts Mortality and Heart Failure Exacerbation But Not Ventricular Arrhythmias in Patients With Cardiomyopathy
    M. Scott Binder, Lisa R. Yanek, Wanjun Yang, Barbara Butcher, Sanaz Norgard, Joseph Edward Marine, Aravindan Kolandaivelu, Jonathan Chrispin, Neal S. Fedarko, Hugh G Calkins et al. · 2023 · Journal of the American Heart Association
22. Circulating Chemerin Levels, but not the RARRES2 Polymorphisms, Predict the Long-Term Outcome of Angiographically Confirmed Coronary Artery Disease
    Leay‐Kiaw Er, Lung‐An Hsu, Jyh‐Ming Jimmy Juang, Fu‐Tien Chiang, Ming‐Sheng Teng, I‐Shiang Tzeng, Semon Wu, Jeng-Feng Lin, Yu‐Lin Ko · 2019 · International Journal of Molecular Sciences
23. High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease
    Willibald Hochholzer, Christian Marc Valina, Christian Stratz, Michael Amann, Daniel Schlittenhardt, Heinz Joachim Büttner, Dietmar Trenk, Franz–Josef Neumann · 2014 · International Journal of Cardiology
24. ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer
    Hanna Aula, Tanja Skyttä, SUVI SIRKKU TUOHINEN, Tiina Hannele Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka M. J. Raatikainen, Eeva Moilanen, Pirkko‐Liisa Kellokumpu‐Lehtinen · 2019 · The Breast
25. Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Suyi Xie, Qi Li, Andrea O. Y. Luk, Hui Y. Lan, Paul K.S. Chan, Antoni Bayés‐Genís, Francis K.L. Chan, Erik Fung · 2022 · Biomolecules
26. Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome
    Zhenhong Fu, Xue Hao, Jun Guo, Lian Chen, Xia Yang, Mingzhi Shen, Wei Dong, Yundai Chen, Geng Qian · 2015 · Clinical Interventions in Aging
27. Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy
    Ki Ryang Na, Yoo H. Kim, Hyo Kyun Chung, Min‐Kyung Yeo, Young Rok Ham, Jin Young Jeong, Koon Soon Kim, Kang W. Lee, Dae Eun Choi · 2017 · Internal Medicine Journal
28. Point-of-Care Testing Devices for Heart Failure Analyzing Blood and Saliva Samples
    Evanthia E. Tripoliti, Penelope Ioannidou, Petros Toumpaniaris, Aidonis Rammos, Dominique Pacitto, Jean-Christophe Lourme, Yorgos Goletsis, Katerina Κ. Naka, Abdelhamid Errachid, Dimitrios I. Fotiadis · 2019 · IEEE Reviews in Biomedical Engineering
29. Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV
    Christopher R. deFilippi, Robert H. Christenson, Jessica M. Joyce, Jakob Park, Ashley Y. Wu, Kathleen V. Fitch, Sara E. Dolan Looby, Michael T. Lu, Udo Hoffmann, Steven Kyle Grinspoon et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
30. The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno–Sobetsu study
    Mizue Fujii, Hirofumi Ohnishi, Shigeyuki Saitoh, Hiroshi Akasaka, Tetsuji Miura, Mitsuru Mori · 2015 · Hypertension Research
31. ST2 and Galectin-3: Ready for Prime Time?
    Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer · 2016 · PubMed Central
32. Novel Biomarkers and the Multiple-Marker Approach in Early Detection, Prognosis, and Risk Stratification of Cardiac Diseases: A Narrative Review
    Ashraf Ullah, Samar Sajid, Maria Qureshi, Muhammad Kamran, Mohammad Ahsan Anwaar, Muhammad Arsal Naseem, Mohammad Uzair Zaman, Fizza Mahmood, Abdur Rehman, Abdullah Shehryar et al. · 2023 · Cureus
33. sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation
    Juan Antonio Vilchez, Montserrat Pérez‐Cuellar, Francisco R. Marín, Pilar Gallego, Sergio Manzano‐Fernández, Mariano Valdés, Vicente Vicente, José Antonio Noguera Velasco, Gregory Y.H. Lip, Jordi Ordóñez‐Llanos et al. · 2015 · European Journal of Clinical Investigation
34. Physical Health Indicators Improve Prediction of Cardiovascular and All-cause Mortality among Middle-Aged and Older People: a National Population-based Study
    Wei‐Ju Lee, Li‐Ning Peng, Shu-Ti Chiou, Liang‐Kung Chen · 2017 · Scientific Reports
35. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study)
    E. Samuli Lepojärvi, Heikki V. Huikuri, Olli-Pekka Piira, Antti M. Kiviniemi, Johanna A. Miettinen, Tuomas V Kenttä, Olavi H. Ukkola, Juha S. Perkiömäki, Mikko Paavo Tulppo, Juhani M. Junttila · 2018 · PLoS ONE
36. Potential associations of circulating growth differentiation factor-15 with sex hormones in male patients with coronary artery disease
    Huan Liu, Wen Dai, Yan Cui, Yongnan Lyu, Yan Li · 2019 · Biomedicine & Pharmacotherapy
37. Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD
    Nathan R. Stein, Leila R. Zelnick, Amanda Hyre Anderson, Robert H. Christenson, Christopher R. deFilippi, Rajat Deo, Alan S. Go, Jiang He, Bonnie Ky, James Phillip Lash et al. · 2020 · Kidney International Reports
38. Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department
    Maros Ferencik, Udo Hoffmann, Fabian Bamberg, James L. Januzzi · 2016 · European Heart Journal
39. Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage
    Milijana Janjusevic, Alessandra Lucia Fluca, Federico Ferro, Giulia Gagno, Yuri D’Alessandra, Antonio Paolo Beltrami, Gianfranco Sinagra, Aneta Aleksova · 2021 · International Journal of Molecular Sciences
40. DXA-Derived vs Standard Anthropometric Measures for Predicting Cardiometabolic Risk in Middle-Aged Australian Men and Women
    Kun Zhu, John P. Walsh, Kevin Murray, Michael L Hunter, Jennie Hui, Joseph Hung · 2022 · Journal of Clinical Densitometry
41. How do high glycemic load diets influence coronary heart disease?
    Marc John Mathews, Leon Liebenberg, Edward Henry Mathews · 2015 · Nutrition & Metabolism
42. Association between high-sensitive troponin I and coronary artery calcification in a Danish general population
    Fredrik J. Olson, Jonathan Engborg, Mette Hjortdal Grønhøj, Niels Peter Rønnow Sand, Jess Lambrechtsen, Flemming Hald Steffensen, Mads Nybo, Oke Gerke, Hans Mickley, Axel Cosmus Pyndt Diederichsen · 2015 · Atherosclerosis
43. ST2 elevation in heart failure, predictive of a high early mortality
    Jamshed J Dalal, Aarti Digrajkar, Barnali Das, Manish Bansal, Avinash Toomu, Alan S. Maisel · 2018 · Indian Heart Journal
44. The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables
    Rocío Carda, Álvaro Aceña, Ana María Pello, Carmen Cristóbal, Nieves Tarín, Ana Isabel Huelmos, Joaquín J. Alonso, Dolores Asensio, Óscar Lorenzo, José Luis Martı́n-Ventura et al. · 2015 · Cardiology
45. Temporal changes of soluble ST 2 after cardiovascular interventions
    Sanne Willems, Jan-Willem E. M. Sels, Suzanne Flier, Dik Versteeg, Wolfgang Bühre, Dominique P.V. de Kleijn, Imo E. Hoefer, Gerard Pasterkamp · 2012 · European Journal of Clinical Investigation
46. A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum
    Magdalena Krintus, Federica Braga, Marek Koziński, Simona Borille, Jacek Kubica, Grażyna Sypniewska, Mauro Panteghini · 2018 · Clinical Chemistry and Laboratory Medicine (CCLM)
47. Innovative Synthesis and Advancement Strategies for GCN as Supercapacitor Electrodes: A Comprehensive Review Revealing New Insights
    Mahdi Saadati pour, Mercedeh Delyanee, Mona Zamani Pedram · 2025 · ACS Applied Energy Materials
48. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction
    Ferran Rueda, Josep Lupón, Cosme García‐García, Germán Cediel, M. Cruz Aranda Nevado, Judith Serra Gregori, Carlos Labata, Teresa Oliveras, Marc Ferrer, Oriol De Diego et al. · 2019 · Clinical Chemistry and Laboratory Medicine (CCLM)
49. Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study
    Paul I. Welsh, Dorien M Kimenai, Anoop S.V. Shah, Danni A. Gadd, Riccardo Emilio Marioni, Mark Woodward, Cathie L. M. Sudlow, Archie Campbell, John G.F. Cleland, Pierpaolo Pellicori et al. · 2023 · Clinical Chemistry
50. Gene expression profiles in engineered cardiac tissues respond to mechanical loading and inhibition of tyrosine kinases
    Fei Ye, Fangping Yuan, Xiaohong Li, Nigel G. F. Cooper, Joseph P. Tinney, Bradley B. Keller · 2013 · Physiological Reports
51. Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria
    Axel Carl Carlsson, Johan Sundström, Juan Jesús Carrero, Stefan Gustafsson, Markus Stenemo, Anders Olof Larsson, Lars Lind, Johan Ärnlöv · 2016 · European Journal of Preventive Cardiology
52. Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction
    Nils Arne Sörensen, Sebastian Ludwig, Nataliya Makarova, Franz–Josef Neumann, Jonas Lehmacher, Tau Sarra Hartikainen, Paul Michael Haller, Till Keller, Stefan Blankenberg, Dirk Westermann et al. · 2019 · Biomolecules
53. Cardiovascular Risk in COPD
    Thibaud Soumagne, Nicolás Roche, Alicia Guillien, Malika Bouhaddi, Steffi Rocchi, Sophie Hüe, Fréderic Claudé, Lucie Bizard, Pascal Andujar, Jean‐Charles Dalphin et al. · 2019 · CHEST Journal
54. A Bayesian approach for inferring global points of departure from transcriptomics data
    Joe Reynolds, Sophie Malcomber, Andrew White · 2020 · Computational Toxicology
55. The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
    Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H.W. Silljé · 2021 · International Journal of Molecular Sciences
56. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis
    Sanne Willems, Paul H.A. Quax, Gert Jan de Borst, J.P.P.M. de Vries, Frans L. Moll, Dominique P.V. de Kleijn, Imo E. Hoefer, Gerard Pasterkamp · 2013 · Atherosclerosis
57. Advances in point-of-care testing for cardiovascular diseases
    Brian Regan, Richard J O’Kennedy, David A. Collins · 2020 · Advances in clinical chemistry
58. Assessment of pulmonary embolism severity and the risk of early death
    Piotr Pruszczyk, Marta Skowrońska, Michał Ciurzyński, Katarzyna Kurnicka, Mareike Lankei, Stavros Konstantinides · 2021 · Polskie Archiwum Medycyny Wewnętrznej
59. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD
    Benjamin Lidgard, Leila R. Zelnick, Amanda Hyre Anderson, Harold I. Feldman, Alan S. Go, Jiang He, Mayank Mohan Kansal, Madhumita Jena Mohanty, Rupal C. Mehta, Michael G. Shlipak et al. · 2022 · Kidney360
60. Ultrasensitive Troponin I and Incident Cardiovascular Disease
    Jean Philippe Empana, Ivan Lerner, Marie‐Cécile Perier, Catherine Guibout, Patricia Jabre, Karine Bailly, Muriel Andrieu, Rachel E. Climie, Thomas T. van Sloten, Benoı̂t Vedie et al. · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
61. Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review
    Maryam Kayani, Neha Fatima, Pooja Chowdary Yarra, Naiela E Almansouri, K Deepshikha, Abirami Balasubramanian, Navya Parvathaneni, Adetola G Mowo-wale, Josue A Valdez, Zahra Nazir · 2024 · Cureus
62. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure
    Jing Bai, Lina Han, Hongbin Liu · 2020 · Annals of Palliative Medicine
63. Soluble ST2 Testing in the General Population
    Jennifer E. Ho, Piyamitr Sritara, Christopher R. deFilippi, Thomas J. Wang · 2015 · The American Journal of Cardiology
64. The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease
    Braden T. Tierney, Yixuan He, George McDonald Church, Eran Segal, Aleksandar David Kostic, Chirag J. Patel · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
65. Putting it into Perspective: Multimarker Panels for Cardiovascular Disease Risk Assessment
    Sahar Taqui, Lori B. Daniels · 2013 · Biomarkers in Medicine
66. Prediction of Left Ventricular Reverse Remodelling: A Mini Review on Clinical Aspects
    Martin Chudý, Eva Gonçalvesová · 2022 · Cardiology
67. High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV
    Nadira Vadaq, Yue Zhang, Wilhelm A. J. W. Vos, Albert L. Groenendijk, Martinus J.T. Blaauw, Louise E. van Eekeren, Maartje C. P. Cleophas, Lisa Van de Wijer, Jéssica Cristina dos Santos, Muhammad Hussein Gasem et al. · 2023 · JCI Insight
68. The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis
    Hongzhen Ma, Jun Zhou, Meng Zhang, Chun Shen, Zhifan Jiang, Tao Zhang, Fei Gao · 2023 · Medical Science Monitor
69. Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials
    Jonathan D. Newman, Rebecca Anthopolos, Kelly V. Ruggles, MacIntosh Cornwell, Harmony R. Reynolds, Sripal Bangalore, Kreton Mavromatis, Claes Held, Lars C. Wallentin, Iftikar J. Kullo et al. · 2023 · American Heart Journal
70. Emerging biomarkers for acute heart conditions
    Vlad C. Vasile, Allan S. Jaffe · 2014 · Current Opinion in Cardiology
71. The Association Between Novel Biomarkers and 1-Year Readmission or Mortality After Cardiac Surgery
    Jeffrey Phillip Jacobs, Shama S. Alam, Sherry L. Owens, Devin M. Parker, Michael E. Rezaee, Donald S. Likosky, David M. Shahian, Marshall Lewis Jacobs, Heather Thiessen‐Philbrook, Moritz C. Wyler von Ballmoos et al. · 2018 · The Annals of Thoracic Surgery
72. Intense sport practices and cardiac biomarkers
    Caroline M. Le Goff, Jordi Farré-Segura, P. Dufour, Jean‐François Kaux, Etienne Cavalier · 2020 · Clinical Biochemistry
73. Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda
    Jasmine P. Kipke, Seunghee Park Margevicius, Cissy M Kityo, Grace Mirembe, Jonathan Buggey, Chun‐Ho Yun, Chung‐Lieh Hung, Grace A. McComsey, Chris Todd Longenecker · 2021 · Journal of the American Heart Association
74. The effect of exercise training on the course of cardiac troponin T and I levels: three independent training studies
    Noreen van der Linden, Lieke J.J. Klinkenberg, Marika Leenders, Michael Tieland, Lex B. Verdijk, Marijke Niens, Jeroen D.E. van Suijlen, C.P.G.M. de Groot, Otto Bekers, Luc J. C. van Loon et al. · 2015 · Scientific Reports
75. Biomarkers for the prediction of venous thromboembolism in the community
    Marja Kaarina Puurunen, Danielle M. Enserro, Vanessa Xanthakis, Martin G. Larson, Emelia J. Benjamin, Geoffrey H. Tofler, Kai Christoph Wollert, Christopher J. O’Donnell, Ramachandran Srini Vasan · 2016 · Thrombosis Research
76. Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives
    Vichai Senthong, Jennifer Kirsop, W.H. Wilson Tang · 2017 · Current Heart Failure Reports
77. Association Between High‐Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women
    Joshua Richard Lewis, Wai H. Lim, Germaine Wong, Samuel Abbs, Kun Zhu, Ee Mun Lim, Peter Lindsay Thompson, Richard Lewis Prince · 2017 · Journal of the American Heart Association
78. Soluble ST2 – a new biomarker in heart failure
    Patric Biaggi, Camille Ammann, Mauro Imperiali, Angelika Hammerer‐Lercher, Tobias Breidthardt, Christian Eugen Mueller, Alan S. Maisel, Frank Thomas Ruschitzka · 2019 · Cardiovascular Medicine
79. Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy
    Justin Sharim, Lori B. Daniels · 2020 · Current Cardiology Reports
80. Association of Lower Plasma Homoarginine Concentrations with Greater Risk of All-Cause Mortality in the Community: The Framingham Offspring Study
    Edzard Schwedhelm, Rebecca J. Song, Ramachandran Srini Vasan, Edwin R. van den Heuvel, Juliane Hannemann, Vanessa Xanthakis, Rainer H. Böger · 2020 · Journal of Clinical Medicine
81. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention
    Qin-Yao Zhang, Meirong Hu, Shumei Ma · 2021 · Journal of Atherosclerosis and Thrombosis
82. Elevated ST 2 levels are associated with antibody‐mediated rejection in heart transplant recipients
    Avishay Grupper, Omar F. AbouEzzeddine, Joseph John Maleszewski, Ayelet Grupper, Jennifer R. Geske, Walter K. Kremers, Sudhir S. Kushwaha, Naveen L. Pereira · 2018 · Clinical Transplantation
83. Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation
    Muhammad Sanusi, Roopeessh Vempati, Dinakaran Umashankar, Suha Tarannum, Yash K. Varma, Fawaz Mohammed, Maneeth Mylavarapu, Faiza Zakaria, Rajiv Chandrasekharan Nair, Yeruva Madhu Reddy et al. · 2025 · Cells
84. Growth Differentiation Factor-15 as a Potent Predictor of Long-Term Mortality among Subjects with Osteoarthritis
    Natalie Arnold, Martin Rehm, Gisela Büchele, Raphael Simon Peter, Rolf Erwin Brenner, Klaus‐Peter Günther, Hermann Brenner, Wolfgang Köenig, Dietrich Rothenbacher · 2020 · Journal of Clinical Medicine
85. Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy
    Edith D. Majonga, L.‐M. Yindom, Dan Hameiri‐Bowen, Justin Mayini, Andrea Mary Rehman, Juan Pablo Kaski, Hilda Angela Mujuru, Sarah Rowland‐Jones, Rashida A. Ferrand · 2022 · AIDS
86. Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study
    Stephan Nopp, Florian Moik, Simon C Kraler, Cornelia Englisch, Matthias Preusser, Arnold von Eckardstein, Ingrid Pabinger, Thomas Felix Lüscher, Cihan Ay · 2023 · Journal of Thrombosis and Haemostasis
87. Troponins and other biomarkers in the early diagnosis of acute myocardial infarction
    Annette Maznyczka, Thomas Edward Kaier, Michael S. Marber · 2015 · Postgraduate Medical Journal
88. Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study
    Keith Colaco, Ker‐Ai Lee, Shadi Akhtari, Raz Winer, Paul I. Welsh, Naveed A. Sattar, Iain B. McInnes, Vinod Chandran, Paula Harvey, Richard J. Cook et al. · 2022 · Arthritis & Rheumatology
89. Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance
    Silvio Quick, Nadine K. Waessnig, Nadine Kandler, David M. Poitz, Steffen Schoen, Karim S. Ibrahim, Ruth H. Strasser, Uwe Speiser · 2015 · Scandinavian Cardiovascular Journal
90. GDF-15 in Heart Failure: Providing Insight Into End-Organ Dysfunction and Its Recovery?
    Kai Christoph Wollert, Tibor Kempf · 2012 · European Journal of Heart Failure
91. Gdf-15 and Soluble St2 As Biomarkers of Right Ventricular Dysfunction in Pulmonary Hypertension
    Stanislav Keranov, Laila Widmann, Leili Jafari, Christoph Liebetrau, Till Keller, Christian Troidl, Steffen Daniel Kriechbaum, Sandra Voss, Pascal Bauer, Manuel Jonas Richter et al. · 2022 · Biomarkers in Medicine
92. Association of circulating growth differentiation factor-15, Krüppel-like factor 4 and growth arrest-specific 6 with coronary artery disease
    Huan Liu, Yongnan Lyu, Di Li, Yan Cui, Wen Dai, Yan Li · 2019 · Clinica Chimica Acta
93. Serial Assessment of Biomarkers and Heart Failure Outcomes in Patients with Atrial Fibrillation
    Kazuma Oyama, Robert Patrick Giugliano, Christian Thomas Ruff, David D. Berg, Petr Jarolı́m, Minao Tang, Jeong‐Gun Park, Hans Lanz, Elliott Marshall Antman, Eugene Braunwald M. D et al. · 2023 · European Journal of Heart Failure
94. Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes
    Óscar M. Peiró, Álvaro García‐Osuna, Jordi Ordóñez‐Llanos, Germán Cediel, Gil Bonet, Sergio Rojas, Verónica Quintern, Alfredo Bardajı́ · 2019 · Clinical Biochemistry
95. Association between GDF15, poverty and mortality in urban middle-aged African American and white adults
    David W. Freeman, Nicole Noren Hooten, Yoonseo Kim, Nicolle A. Mode, Ngozi Ejiogu, Alan B. Zonderman, Michele K. Evans · 2020 · PLoS ONE
96. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
    Naglaa Makram Farag, Mahmoud Mohamed Mousa, Eman Elsayed, ahlam ismeil · 2023 · The Italian Journal of Pediatrics/Italian journal of pediatrics
97. Identifying proteins and pathways associated with multimorbidity in 53,026 adults
    Yi-Lin Chen, Jia You, Yu Guo, Yi Zhang, Bing-Ran Yao, Jijing Wang, Shi-Dong Chen, Yi‐Jun Ge, Yang Liu, Xinrui Wu et al. · 2024 · Metabolism
98. Biomarkers in Heart Failure
    Andrea Salzano, Roberta D’Assante, Muhammad Zubair Israr, Mohamed M. Eltayeb, Anna Grazia D'Agostino, Dennis Bernieh, Mariarosaria De Luca, Salvatore Rega, Brigida Ranieri, Ciro Mauro et al. · 2021 · Heart Failure Clinics
99. Troponin
    Richard L. Popp · 2013 · Journal of the American College of Cardiology
100. New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations
     Elles M. Screever, Wouter C. Meijers, Dirk Jan van Veldhuisen, Rudolf A. de Boer · 2017 · Expert Opinion on Pharmacotherapy